JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oberste-Berghaus, C.
Right arrow Articles by Wondisford, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oberste-Berghaus, C.
Right arrow Articles by Wondisford, F. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 3, 1787-1792, January 21, 2000

Thyroid Hormone-independent Interaction between the Thyroid Hormone Receptor beta 2 Amino Terminus and Coactivators*

Corinna Oberste-BerghausDagger , Kerstin ZangerDagger , Koshi Hashimoto, Ronald N. Cohen, Anthony N. Hollenberg, and Fredric E. Wondisford*

From the Thyroid Unit, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215

Thyroid hormone receptors (TRs) mediate hormone action by binding to DNA response elements (TREs) and either activating or repressing gene expression in the presence of ligand, T3. Coactivator recruitment to the AF-2 region of TR in the presence of T3 is central to this process. The different TR isoforms, TR-beta 1, TR-beta 2, and TR-alpha 1, share strong homology in their DNA- and ligand-binding domains but differ in their amino-terminal domains. Because TR-beta 2 exhibits greater T3-independent activation on TREs than other TR isoforms, we wanted to determine whether coactivators bound to TR-beta 2 in the absence of ligand. Our results show that TR-beta 2, unlike TR-beta 1 or TR-alpha 1, is able to bind certain coactivators (CBP, SRC-1, and pCIP) in the absence of T3 through a domain which maps to the amino-terminal half of its A/B domain. This interaction is specific for certain coactivators, as TR-beta 2 does not interact with other co-factors (p120 or the CBP-associated factor (pCAF)) in the absence of T3. The minimal TR-beta 2 domain for coactivator binding is aa 21-50, although aa 1-50 are required for the full functional response. Thus, isoform-specific regulation by TRs may involve T3-independent coactivator recruitment to the transcription complex via the AF-1 domain.


* This work was supported by grants from the National Institute of Health (to R. N. C., A. N. H., and F. E. W.) and by a research grant of the Deutschen Akademischen Austauschdienst (to C. O. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger These authors contributed equally to the study.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
F. Flamant, K. Gauthier, and J. Samarut
Thyroid Hormones Signaling Is Getting More Complex: STORMs Are Coming
Mol. Endocrinol., February 1, 2007; 21(2): 321 - 333.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Tian, M. A. Mahajan, C. T. Wong, I. Habeos, and H. H. Samuels
The N-Terminal A/B Domain of the Thyroid Hormone Receptor-{beta}2 Isoform Influences Ligand-Dependent Recruitment of Coactivators to the Ligand-Binding Domain
Mol. Endocrinol., September 1, 2006; 20(9): 2036 - 2051.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Iwasaki, A. Takeshita, W. Miyazaki, W. W. Chin, and N. Koibuchi
The Interaction of TR{beta}1-N Terminus with Steroid Receptor Coactivator-1 (SRC-1) Serves a Full Transcriptional Activation Function of SRC-1
Endocrinology, March 1, 2006; 147(3): 1452 - 1457.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Wan, B. Farboud, and M. L. Privalsky
Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function
Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-W. Kim, S.-C. Ho, S.-J. Hong, K. M. Kim, E. C. So, M. Christoffolete, and J. W. Harney
A Novel Mechanism of Thyroid Hormone-dependent Negative Regulation by Thyroid Hormone Receptor, Nuclear Receptor Corepressor (NCoR), and GAGA-binding Factor on the Rat CD44 Promoter
J. Biol. Chem., April 15, 2005; 280(15): 14545 - 14555.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Shibusawa, A. N. Hollenberg, and F. E. Wondisford
Thyroid Hormone Receptor DNA Binding Is Required for Both Positive and Negative Gene Regulation
J. Biol. Chem., January 3, 2003; 278(2): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Vasudevan, S. Ogawa, and D. Pfaff
Estrogen and Thyroid Hormone Receptor Interactions: Physiological Flexibility by Molecular Specificity
Physiol Rev, October 1, 2002; 82(4): 923 - 944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Macchia, P. Jiang, Y.-D. Yuan, R. A. S. Chandarardna, R. E. Weiss, O. Chassande, J. Samarut, S. Refetoff, and C. F. Burant
RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E326 - E331.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Takeuchi, Y. Murata, P. Sadow, Y. Hayashi, H. Seo, J. Xu, B. W. O'Malley, R. E. Weiss, and S. Refetoff
Steroid Receptor Coactivator-1 Deficiency Causes Variable Alterations in the Modulation of T3-Regulated Transcription of Genes in Vivo
Endocrinology, April 1, 2002; 143(4): 1346 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M.-C. Zennaro, A. Souque, S. Viengchareun, E. Poisson, and M. Lombes
A New Human MR Splice Variant Is a Ligand-Independent Transactivator Modulating Corticosteroid Action
Mol. Endocrinol., September 1, 2001; 15(9): 1586 - 1598.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Yang and M. L. Privalsky
Isoform-Specific Transcriptional Regulation by Thyroid Hormone Receptors: Hormone-Independent Activation Operates through a Steroid Receptor Mode of Coactivator Interaction
Mol. Endocrinol., July 1, 2001; 15(7): 1170 - 1185.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev, July 1, 2001; 81(3): 1097 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Aranda and A. Pascual
Nuclear Hormone Receptors and Gene Expression
Physiol Rev, July 1, 2001; 81(3): 1269 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. M. Tolón, A. I. Castillo, A. M. Jiménez-Lara, and A. Aranda
Association with Ets-1 Causes Ligand- and AF2-Independent Activation of Nuclear Receptors
Mol. Cell. Biol., December 1, 2000; 20(23): 8793 - 8802.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
G. R. Williams
Cloning and Characterization of Two Novel Thyroid Hormone Receptor beta Isoforms
Mol. Cell. Biol., November 15, 2000; 20(22): 8329 - 8342.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.